Morganville, NJ, United States of America

Shieh-Shung T Chen


Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 393(Granted Patents)


Location History:

  • Morgansville, NJ (US) (1993)
  • Morganville, NJ (US) (1990 - 2003)

Company Filing History:


Years Active: 1990-2003

Loading Chart...
48 patents (USPTO):Explore Patents

Title: Shieh-Shung T. Chen: Innovator in Antidiabetic Compounds and Biotransformation Processes

Introduction

Shieh-Shung T. Chen, based in Morganville, NJ, is a prominent inventor with an impressive portfolio of 48 patents. His contributions to the fields of biochemistry and pharmaceutical sciences have paved the way for advancements in treating diabetes and enhancing the efficiency of drug formulations.

Latest Patents

Among his latest inventions, Chen has developed a series of antidiabetic 4-hydroxy-2-furoic acids. These substituted acids, derived through the fermentation of an asterriquinone, exhibit a unique structure that modulates insulin receptor tyrosine kinase activity. This innovation holds promise for treating diabetes and conditions associated with impaired insulin response or production. Additionally, Chen's work in the microbial transformation of taxol and cephalomannine has yielded procedures for creating hydroxylated derivatives, including methods for converting taxol to L-760,006 and L-760,007, and cephalomannine to L-745,596.

Career Highlights

Shieh-Shung T. Chen has made significant strides in his career, working with notable companies such as Merck & Company, Inc. and the Purdue Research Foundation. His deep understanding of biochemical processes and innovative mindset has led to valuable patents that contribute to modern therapeutic approaches.

Collaborations

Throughout his career, Chen has collaborated with distinguished professionals in his field, including Byron H. Arison and Raymond F. White. These collaborations have facilitated the exchange of ideas and advancements in research, further enhancing the quality of his inventions.

Conclusion

Shieh-Shung T. Chen continues to be a leading figure in the realm of innovation, particularly in the development of antidiabetic compounds and biotransformation methods. His extensive patent portfolio not only illustrates his creativity but also marks his influential status in the scientific community. As research evolves, Chen’s contributions are likely to have lasting impacts on healthcare and pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…